P1313: LOW DOSE RITUXIMAB FOR PRE-EMPTIVE TREATMENT OF EPSTEIN BARR VIRUS REACTIVATION AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER STUDY

HemaSphere (Aug 2023)

Affiliations

Chen Mei: 1 The First Affiliated Hospital, College of Medicine, Zhejiang University, Department of Hematology, Hangzhou, China
Yanling Ren: 1 The First Affiliated Hospital, College of Medicine, Zhejiang University, Department of Hematology, Hangzhou, China
Jiejin Qian: 1 The First Affiliated Hospital, College of Medicine, Zhejiang University, Department of Hematology, Hangzhou, China
Hongyan Tong: 1 The First Affiliated Hospital, College of Medicine, Zhejiang University, Department of Hematology, Hangzhou, China

Abstract

No abstracts available.

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.hemaspherejournal.com